Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

Klinik und Poliklinik für Kinder- und Jugendmedizin

Klinikum / Johannes Gutenberg-Universität Mainz

Forschungsprojekte
Ergebnisse pro Seite:  10

2018 - 2025

A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled 3-Part Trial of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in Subjects With Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease
  • Prof. Dr. Julia Hennermann

2018 - 2023

Comprehensive Assessments and Related interventions to Enhance long-term outcome in Children, Adolescents and Young Adults
  • Univ.-Prof. Dr. med. Jörg Faber

2018 - 2025

A Phase 3 Randomized, Multicenter, Multinational, Double-blinded Study Comparing the Efficacy and Safety of Repeated Biweekly Infusions of Avalglucosidase Alfa (neoGAA, GZ402666) and Alglucosidase Alfa in Treatment naïve Patients With Late-onset Pompe Disease
  • Prof. Dr. Julia Hennermann

2018 - 2029

IntReALL HR 2010 International Study for Treatment of High Risk Childhood Relapsed ALL 2010
  • Univ.-Prof. Dr. med. Jörg Faber,
  • Dr. med. Arthur Wingerter,
  • Dr. med. Alexandra Russo

2018 - 2021

EFC14028-COMET mit Substanz GZ402666-neoGAA (Phase 3 klinische Studie)
  • Univ.-Prof. Dr. Julia B Hennermann

2018 - 2020

VX17-445-105
  • Dr. Krystyna Poplawska,
  • Dr. Oliver Nitsche

2018 - 2020

VX17-445-102
  • Dr. Krystyna Poplawska,
  • Dr. Oliver Nitsche

2018 - 2021

ASPH-Nanokapseln
  • Univ.-Prof. Dr. Stephan Gehring,
  • Dr. Michael Fichter

2018 - 2019

CART-19 therapy
  • Univ.-Prof. Dr. Jörg Faber,
  • Dr. Claudia Paret

2017 - 2021

PRIMAL - The role of the microbiota for the development of the immune system at the beginning of life
  • Univ.-Prof. Dr. Stephan Gehring,
  • Dr. Claudius Meyer